Selective silencing of RNF181 resulted to a significant downregulation of the expression of NEDD4, suggesting a hypothesis that the silencing of RNF181 may increase the degradation of VEGFR2 via NEDD4 in CAD. This evidence concerns the gene NEDD4 and coronary artery disorder.